Dr. Atul Varadhachary, Managing Partner, Fannin Innovation Studio

Dr. Atul Varadhachary is Managing Partner at Fannin Innovation Studio, Houston’s most active life sciences development group. Fannin in-licenses and develops academic research in the life sciences through clinical proof of concept (http://goo.gl/cFyPky). Fannin’s fifteen active technologies are split evenly between therapeutics and medical devices. Before Fannin, Atul was President of U.S. Operations at Reliance Life Sciences. As President & COO of Agennix, Inc. Atul led advancement of Agennix’s lead molecule from preclinical studies into pivotal Phase 3 human studies and helped lead a successful sale of the company. Atul also served as a Senior Engagement Manager in the Houston office of McKinsey & Co. from 1994-2001. Atul serves as an Adjunct Professor at Rice University, Baylor College of Medicine and the UT School of Public Health and is on several company and community Boards including BioHouston. Atul received his medical training at the University of Bombay and a Ph.D. in Physiology from the Johns Hopkins School of Medicine in Baltimore, followed by a postdoctoral fellowship in Biological Chemistry, also at Johns Hopkins.

Back to 2018 Conference Speakers